Cargando…

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy

Cardiotoxicity due to anthracyclines, trastuzumab and other potential cardiotoxic drugs is still a problem of modern chemotherapy. For years researchers have tried to find biological markers that can predict changes in the heart. The most thoroughly tested markers are troponin and natriuretic peptid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stachowiak, Paweł, Kornacewicz-Jach, Zdzisława, Safranow, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	State of the Art Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223124/ https://www.ncbi.nlm.nih.gov/pubmed/25395954 http://dx.doi.org/10.5114/aoms.2013.34987

Ejemplares similares

The paradox of the first cycle of chemotherapy—transient improvement of contractility and diastolic function after the first cycle of anthracycline-based chemotherapy: a prospective clinical trial
por: Stachowiak, Paweł, et al.
Publicado: (2017)

Update of treatment of heart failure with reduction of left ventricular ejection fraction
por: Aronow, Wilbert S.
Publicado: (2016)

Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Medical Management of Patients With Heart Failure and Reduced Ejection Fraction
por: Greenberg, Barry
Publicado: (2022)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance
por: Aengevaeren, Vincent L., et al.
Publicado: (2021)

Murine Models of Heart Failure With Preserved Ejection Fraction: A “Fishing Expedition”
por: Valero-Muñoz, Maria, et al.
Publicado: (2017)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
por: van Ham, Willem B., et al.
Publicado: (2022)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Rosalia, Luca, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models
por: Withaar, Coenraad, et al.
Publicado: (2021)

Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
por: Sinha, Aish, et al.
Publicado: (2021)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Vascular Dysfunction Predicts Future Deterioration of Left Ventricular Ejection Fraction in Patients with Heart Failure with Mildly Reduced Ejection Fraction
por: Kishimoto, Shinji, et al.
Publicado: (2021)

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
por: Frantz, Stefan, et al.
Publicado: (2022)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan
por: Yandrapalli, Srikanth, et al.
Publicado: (2017)

Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications
por: Heuts, Samuel, et al.
Publicado: (2022)

Real-World Data on the Intravascular Microaxial Left Ventricular Flow Pump (Impella) in High-Risk Patients
por: Rao, Sunil V.
Publicado: (2021)

Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction
por: Baumert, Bartłomiej, et al.
Publicado: (2019)

The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction
por: Peregud-Pogorzelska, Małgorzata, et al.
Publicado: (2020)

Clinical Determinants of Left Ventricular Ejection Fraction Deterioration in Patients Suffered From Complete Left Bundle Branch Block
por: Hashemi Jazi, Mohammad, et al.
Publicado: (2015)

Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

Aliskiren – an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension
por: Zaporowska-Stachowiak, Iwona, et al.
Publicado: (2013)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Updates in Ventricular Tachycardia Ablation
por: Campbell, Timothy, et al.
Publicado: (2020)

Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/Flutter
por: Aoyama, Daisetsu, et al.
Publicado: (2020)

Comprehensive assessment of coronary fractional flow reserve
por: Qi, Xiaolong, et al.
Publicado: (2015)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases
por: Safranow, Krzysztof, et al.
Publicado: (2010)

Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects
por: Song, Jinyoung
Publicado: (2023)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2020)

How to standardize the measurement of left ventricular ejection fraction
por: Kusunose, Kenya, et al.
Publicado: (2021)

Leap or lag: left atrial appendage closure and guidelines
por: Camm, A John
Publicado: (2023)

The effect of idiopathic premature ventricular complexes on left ventricular ejection fraction
por: Altıntaş, Bernas, et al.
Publicado: (2019)

Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias
por: Schwartz, Peter J., et al.
Publicado: (2022)

Independent Value of Cardiac Troponin T and Left Ventricular Global Longitudinal Strain in Predicting All-Cause Mortality among Stable Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction
por: Sung, Junne-Ming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d04rbhslj2tg690vf8vh2uecmg